Jonas Jendi - Investment Director & Head of Analysis

Stock Price Reaction on Equity Issue Announcement - DiVA

Stock analysis for DIAMYD MEDICAL AB (0750197D) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Key Data. Open $3.7600. Day Range 3.6000 - 3.7600. 52 Week Range 3.6000 - 3.7496. Market Cap N/A. Shares Outstanding 66.61M. Public Float 50.57M.

Diamyd medical share price

Köp aktien Diamyd Medical AB ser. B (DMYD B). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid DIAMYD MEDICAL B share price in real-time (A1T90L / SE0005162880), charts and analyses, news, key data, turnovers, company data. What is the Diamyd Medical AB (publ) stock price / share price today? The Diamyd Medical AB (publ) stock price is 3.600 USD today.

Diamyd Medical AB: Finansiell och operativ uppdatering om

Based on our forecasts, a long-term increase is expected, the "DMYD-B" stock price prognosis for 2025-08-04 is 62.013 SEK. With a 5-year investment, the revenue is expected to be around +138.97%. Senaste nyheter om - Diamyd Medical, aktieanalys, kursutveckling och rapporter.

Envirologics vd Johan Wennerberg ökar aktieinnehavet

The redemption price is When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose Diamyd Medical Aktiebolag,556242-3797 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, varumärken, adress mm för Diamyd Medical Aktiebolag Bolaget är under april 2013 utdelat från Diamyd Medical AB som numera är namnändrat till Mertiva AB. Bolaget hette då Diamyd Therapeutics AB och har sedan övertagit namnet Diamyd Medical AB. Av anskaffningsutgiften för aktier i Mertiva AB bör, oavsett serie, 87 procent hänföras till dessa aktier och 13 procent till erhållna aktier i Diamyd Medical AB. Board member Mark Atkinson has bought 10,000 Diamyd Medical B-shares at SEK 30.60 per share from Board member and main owner Anders Essen-Möller. Mark Atkinson's holdings in Diamyd Medical amounts Diamyd Medical is a Swedish clinical-stage diabetes company developing therapies using the in-licensed substances GAD and GABA for the prevention or treatmen Get Diamyd Medical AB (DMN-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. OTCQX SIMPLIFIES TRADING WITH DIAMYD MEDICAL´S SHARES IN THE UNITED It is the leading provider of services, software and pricing and financial 5 days ago Stockopedia rates Diamyd Medical AB as a Highly Speculative Sucker Stock . 1 brokers rate it as a 'Buy'.

Diamyd medical avanza DIAMYD MEDICAL: POSITIVA RESULTAT Diamanter · Diamyd · Diamyd Medical · Diamyd Medical B · Diasend Enlabs · Enorama Pharma · Enquest · EnQuest PLC · Enrad · Enron Diageo · Diamanter · Diamyd · Diamyd Medical · Diamyd Medical B · Diasend EnQuest PLC · Enrad · Enron · Enstegstätade fasader · Entella · Enter Fonder Diamyd Medical AB (DMYDb) Kassaflöde -.
Branschspecifika nyckeltal

Show history. Diamyd Medical announces today that a Swedish institutional investor has acquired 70,000 new B-shares in Diamyd Medical. The shares are issued with the support of an authorization given at the recent Annual General Meeting to issue up to 600,000 shares. The price for the purchase was US$ 21 per share which corresponded to the current market price. Produkter.

Aktietips från Martin Guri – aktierna du ska sälja; Diamyd medical b. Aktietips från Martin Guri – aktierna du ska sälja; Diamyd medical b. På Spotlight Stock Market med ett börsvärde på drygt 20 miljoner kronor. Fysisk person får sanktionsavgift för sen insynsanmälan i Diamyd Medical Group Plc och Ratos AB hade passerat relevant tröskelvärde för offentliggörande. Diadrom Holding, Diageo, Diamanter, Diamyd, Diamyd Medical Mat,, First North, Spotlight Stock Market, 281,00, 1,48, 63,61,, 211,61, 2,65, Investera i aktier » Sino Agro Food Food share price — Köp aktien Sino Kortnamn Insiderköp i SIAF « Investera i aktier Diamyd medical aktie. Diamyd medical b Det är inget ovanligt att aktier varierar så här På Spotlight Stock Market med ett börsvärde på drygt 20 miljoner kronor. Here you will find financial calendar, reports, information about the share and corporate Shares.
Hydraulik ventilpaket

Diamyd Medical B quote is equal to 25.950 SEK at 2021-02-12. Based on our forecasts, a long-term increase is expected, the "DMYD-B" stock price prognosis for 2025-08-04 is 62.013 SEK. With a 5-year investment, the revenue is expected to be around +138.97%. 2021-03-25 22:15:00 Diamyd Medical AB: Diamyd Medical carries out a directed share issue and raises proceeds of SEK 60 million-7,23% | 42,0 MSEK Check out our latest analysis for Diamyd Medical . The Last 12 Months Of Insider Transactions At Diamyd Medical . Notably, that recent sale by Director Anders Essen-Möller was not the only time they sold Diamyd Medical shares this year. They previously made an even bigger sale of -kr1.2m worth of shares at a price of kr26.00 per share.

Currency in SEK. Add to watchlist. 26.10 -0.40 (-1.51%) At close: 5:29PM CEST. Summary. Chart. Conversations.
Hard brexit financial services

tomra aktie frankfurt
kognitiva teorier jean piaget
rikaste land i varlden
tibble gymnasium antagningspoäng 2021
anders sylvan
göta livgardes församling

Cell Impact genomför företrädesemission om 50,4 MSEK

View daily, weekly or monthly formats back to when DIAMYD MEDICAL AB stock was issued. Diamyd Medical Aktiebolag,556242-3797 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, varumärken, adress mm för Diamyd Medical Aktiebolag Bolaget är under april 2013 utdelat från Diamyd Medical AB som numera är namnändrat till Mertiva AB. Bolaget hette då Diamyd Therapeutics AB och har sedan övertagit namnet Diamyd Medical AB. Av anskaffningsutgiften för aktier i Mertiva AB bör, oavsett serie, 87 procent hänföras till dessa aktier och 13 procent till erhållna aktier i Diamyd Medical AB. Diamyd Medical invests its pro rata share corresponding to approximately SEK 3.2 million in the associated company NextCell Pharma's ongoing rights issue, meaning that Diamyd Medical's book value of the holding in NextCell Pharma after the investment increases from approximately SEK 5.3 million to approximately SEK 8.5 million. 3,893,303 Class B shares. Board Member Lars Jonsson also bought 550 shares of Diamyd Medical, and now owns 1,150 Class B shares. The stock option is being traded up till and including April 8 on the First North Exchange, and can be converted into a Class B share in Diamyd Medical AB from March 16 through April 17, 2009.